CClinicalTrials.gg
CompletedNCT05558202Updated Aug 2, 2023

Turkish Version of The Lower Limb Assessment Score

An observational study in Hypermobility, Joint, sponsored by Kutahya Health Sciences University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-08-02.

Sponsored by Kutahya Health Sciences University · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
90
Ages
18 Years to 35 Years
Sex
All
01

Study summary

Hypermobility is more than normal joint laxity, mobility, and range of motion. It is characterized by increased laxity and fragility of connective tissues. Symptoms from hypermobility can begin at any age and affect women more than men. People are at higher risk than other people. It is stated that hypermobility is an important factor in orthopedic injuries and diseases. Individuals with hypermobility have more frequent orthopedic complaints and the problems are usually idiopathic and chronic. Studies have reported that proprioception and musculoskeletal reflex function may be affected independently of symptoms in hypermobile individuals. Therefore, evaluating hypermobility is very important in preventing hypermobility-related problems and injuries and developing appropriate treatment methods. Although the Beighton score is the most commonly used scoring method to determine hypermobility, it may be insufficient to determine hypermobility of the lower extremities. The Lower Limb Assessment Score (LLAS) has been reported to be one of the most appropriate scoring methods for assessing lower extremity hypermobility in the literature. The aim of this study is to adapt LLAS to Turkish and measure its validity and reliability.

02

Conditions studied

  • Hypermobility, Joint

Browse trials for

03

In context

Joint Instability

147 studies on the registry are indexed under Joint Instability; 22 are open to participants now.

This study's enrollment of 90 is above the median of 58 across 66 observational studies indexed under Joint Instability.

Browse Joint Instability studies →

Lead sponsor

Kutahya Health Sciences University is the lead sponsor of 209 studies on the registry; 46 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

  • The study will be carried out by young adults and adults in the Kutahya Health Science University

Inclusion criteria

  • Healthy volunteers
  • Aged between 18 to 35

Exclusion criteria

Exclusion Criteria:

  • Using assistive devices or orthoses for the upper extremity
  • Surgery history of the upper extremity
  • Pain located on the upper extremity in the last 6 months
  • Previous trauma that might restrict normal range of motion.
  • Having degenerative or inflamatuar disease
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
90 participants (actual)
Patient registry
No

Interventions

  • OtherTurkish validity and reliability

    1. Explanation of the Turkish version of the scale. 2. Translating the Turkish version of the scale into English to ensure consistency with the original scale. 3. First application of scales to participants by two examiners separately. 4. Second application of the scales to the participants by one examiner. 5. Statistical analysis and scaling

06

What researchers measure

Primary outcomes

  1. The Lower Limb Assessment Score (LLAS)

    The LLAS was designed to test the mobility of many joints of the lower limb in multiple planes of motion. These tests include passive physiological, passive accessory and active range of motion. The LLAS is performed on both lower limbs, each providing a score to a maximum of 12.

    Time frame: 10 minutes

  2. The Beighton Score

    The Beighton Score is a set of manoeuvres used as the standard method of assessment for Generalised Joint Hypermobility. The Beighton score arbitrarily investigates the presence of hyperlaxity (yes = 1, no = 0) at both wrists, the fifth metacarpo-phalangeal joints, elbows, knee joints, and the lumbosacral spine. The items are summed and yield a Beighton score ranging from 0 to 9 points.

    Time frame: 5 minutes

07

Study locations

1 site
  • Kutahya Health Science University
    Kutahya, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 2, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05558202
Lead sponsor
Kutahya Health Sciences University
Responsible party
Emrah Afsar (Head of Occupational Therapy Deparment, Kutahya Health Sciences University) — Principal investigator
First posted
Sep 28, 2022
Start date
Sep 30, 2022
Primary completion
Oct 30, 2022
Completion
Dec 30, 2022
Last update
Aug 2, 2023

Study contacts

Emrah Afsar, Phd
principal investigator · Kutahya Health Sciences University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion